MigraineMind research summary
2026 Taiwan guidelines for the acute pharmacologic treatment of migraine in adults.
J Chin Med Assoc | 2026
Guideline / consensusSummary
Recent updates to Taiwan's migraine treatment guidelines reflect new advances in medicine. The Taiwan Headache Society reviewed both pharmacological and non-pharmacological treatments. They used evidence-based principles to ensure the guidelines are relevant. The committee looked at the latest international guidelines and expert opinions. This revision clarifies treatment roles and grades of recommendation. It also discusses the effectiveness and side effects of various treatments. Patients in Taiwan have access to a wide range of medications for migraine management. These medications are divided into "specific" and "non-specific" agents. Specific treatments include triptans and gepants, which target migraine symptoms. Non-specific agents consist of common pain relievers like acetaminophen and NSAIDs. This comprehensive approach aims to provide better options for migraine sufferers. By staying updated, the guidelines help clinicians offer the best care possible for patients experiencing migraines. Clinical relevance: These updated guidelines provide healthcare professionals with the latest treatment options for managing migraines effectively.
Key Learning Points
- Taiwan's updated migraine treatment guidelines incorporate the latest medical advances and evidence-based practices.
- Patients in Taiwan have access to a variety of medications specifically designed for migraine management.
- Specific treatments like triptans and gepants are available for targeting migraine symptoms effectively.
- Non-specific agents, such as acetaminophen and NSAIDs, are also included for broader pain relief options.
- Clinicians can provide improved care by following these updated guidelines and understanding treatment roles.
Original research
Read the original publication and review its full methods and findings on PubMed.
MigraineMind is an educational resource designed to complement—not replace—the original scientific literature or clinical judgement. This page is an AI-generated summary of the available paper information and may contain errors. Please consult the original publication.